Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts. more
Time Frame | RGEN | Sector | S&P500 |
---|---|---|---|
1-Week Return | 4.08% | -3.39% | 0.2% |
1-Month Return | 28.14% | -1.92% | 2.72% |
3-Month Return | 15.95% | -10.54% | 7.31% |
6-Month Return | 27.17% | -4.47% | 10.44% |
1-Year Return | -10.53% | 4.06% | 27.53% |
3-Year Return | -40.42% | 0.94% | 30.88% |
5-Year Return | 74.95% | 36.67% | 89.21% |
10-Year Return | 655.93% | 102.87% | 199.95% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 270.25M | 366.26M | 670.53M | 801.54M | 638.76M | [{"date":"2019-12-31","value":33.72,"profit":true},{"date":"2020-12-31","value":45.69,"profit":true},{"date":"2021-12-31","value":83.66,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":79.69,"profit":true}] |
Cost of Revenue | 119.10M | 156.63M | 279.28M | 345.83M | 354.52M | [{"date":"2019-12-31","value":33.59,"profit":true},{"date":"2020-12-31","value":44.18,"profit":true},{"date":"2021-12-31","value":78.78,"profit":true},{"date":"2022-12-31","value":97.55,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 151.15M | 209.63M | 391.25M | 455.71M | 284.25M | [{"date":"2019-12-31","value":33.17,"profit":true},{"date":"2020-12-31","value":46,"profit":true},{"date":"2021-12-31","value":85.86,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":62.38,"profit":true}] |
Gross Margin | 55.93% | 57.23% | 58.35% | 56.85% | 44.50% | [{"date":"2019-12-31","value":95.85,"profit":true},{"date":"2020-12-31","value":98.09,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.44,"profit":true},{"date":"2023-12-31","value":76.26,"profit":true}] |
Operating Expenses | 115.06M | 139.80M | 218.14M | 259.76M | 230.27M | [{"date":"2019-12-31","value":44.3,"profit":true},{"date":"2020-12-31","value":53.82,"profit":true},{"date":"2021-12-31","value":83.98,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":88.64,"profit":true}] |
Operating Income | 14.90M | 42.54M | 133.50M | 133.61M | 54.58M | [{"date":"2019-12-31","value":11.15,"profit":true},{"date":"2020-12-31","value":31.84,"profit":true},{"date":"2021-12-31","value":99.92,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":40.85,"profit":true}] |
Total Non-Operating Income/Expense | 1.96M | (22.74M) | (26.42M) | (8.51M) | 6.64M | [{"date":"2019-12-31","value":29.47,"profit":true},{"date":"2020-12-31","value":-342.2,"profit":false},{"date":"2021-12-31","value":-397.59,"profit":false},{"date":"2022-12-31","value":-128.02,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | 26.15M | 59.22M | 153.54M | 219.14M | 64.13M | [{"date":"2019-12-31","value":11.93,"profit":true},{"date":"2020-12-31","value":27.02,"profit":true},{"date":"2021-12-31","value":70.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":29.27,"profit":true}] |
Income Taxes | 4.74M | (709.00K) | 25.25M | 33.18M | 22.55M | [{"date":"2019-12-31","value":14.29,"profit":true},{"date":"2020-12-31","value":-2.14,"profit":false},{"date":"2021-12-31","value":76.1,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":67.98,"profit":true}] |
Income After Taxes | 21.41M | 59.93M | 128.29M | 185.96M | 41.58M | [{"date":"2019-12-31","value":11.51,"profit":true},{"date":"2020-12-31","value":32.23,"profit":true},{"date":"2021-12-31","value":68.99,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":22.36,"profit":true}] |
Income From Continuous Operations | 21.41M | 59.93M | 128.29M | 185.96M | 115.79M | [{"date":"2019-12-31","value":11.51,"profit":true},{"date":"2020-12-31","value":32.23,"profit":true},{"date":"2021-12-31","value":68.99,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":62.27,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 21.41M | 59.93M | 128.29M | 185.96M | 41.58M | [{"date":"2019-12-31","value":11.51,"profit":true},{"date":"2020-12-31","value":32.23,"profit":true},{"date":"2021-12-31","value":68.99,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":22.36,"profit":true}] |
EPS (Diluted) | 1.05 | 1.66 | 3.06 | 3.28 | 1.73 | [{"date":"2019-12-31","value":32.01,"profit":true},{"date":"2020-12-31","value":50.61,"profit":true},{"date":"2021-12-31","value":93.29,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":52.74,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
RGEN | |
---|---|
Cash Ratio | 7.23 |
Current Ratio | 10.44 |
Quick Ratio | 8.76 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
RGEN | |
---|---|
ROA (LTM) | 0.20% |
ROE (LTM) | -0.10% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
RGEN | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.29 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.71 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
RGEN | |
---|---|
Trailing PE | NM |
Forward PE | 98.04 |
P/S (TTM) | 14.09 |
P/B | 4.35 |
Price/FCF | 214 |
EV/R | 13.52 |
EV/Ebitda | 82.43 |
PEG | 2.59 |
Repligen Corporation (RGEN) share price today is $156.805
Yes, Indians can buy shares of Repligen Corporation (RGEN) on Vested. To buy Repligen Corporation from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RGEN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Repligen Corporation (RGEN) via the Vested app. You can start investing in Repligen Corporation (RGEN) with a minimum investment of $1.
You can invest in shares of Repligen Corporation (RGEN) via Vested in three simple steps:
The 52-week high price of Repligen Corporation (RGEN) is $211.13. The 52-week low price of Repligen Corporation (RGEN) is $113.5.
The price-to-earnings (P/E) ratio of Repligen Corporation (RGEN) is
The price-to-book (P/B) ratio of Repligen Corporation (RGEN) is 4.35
The dividend yield of Repligen Corporation (RGEN) is 0.00%
The market capitalization of Repligen Corporation (RGEN) is $9.02B
The stock symbol (or ticker) of Repligen Corporation is RGEN